Tempus

Senior Integration Analyst

Illinois, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Information TechnologyIndustries

Requirements

Candidates should have 8+ years of experience in healthcare data integration, EHR interoperability, or a related field. Proficiency in HL7 v2, FHIR R4, API-based integrations, and clinical data standards is required. Experience with EHRs like Epic, Cerner, or Flatiron, familiarity with Unix command-line and Git, and the ability to edit Java or Python scripts are necessary. Hands-on experience with data transformation, validation, ETL tools, interface engines, strong SQL skills, and experience with APIs (REST, SOAP, OAuth 2.0) are essential. A strong understanding of HIPAA, PHI data security, and regulatory compliance is also required, along with experience in monitoring and logging tools. Strong communication skills and the ability to manage multiple priorities are important.

Responsibilities

The Senior Integration Analyst will collaborate with external providers and internal teams to implement EHR/EMR integrations, including order and result interfaces, clinical data ingestion, and interoperability workflows. They will support new customer onboarding by providing technical guidance and issue resolution. Responsibilities include analyzing, mapping, and validating healthcare data from various EHR platforms to ensure compliance with interoperability standards. The role involves monitoring data quality, troubleshooting issues, and working with engineering and product teams to optimize integration workflows. Maintaining and documenting best practices, integration guides, and standard operating procedures is also a key duty, along with supporting the connectivity and data integration roadmap.

Skills

HL7 v2
FHIR R4
API
EHR integration
EMR integration
HL7
FHIR
data integration
healthcare data
Epic
Cerner
Athena

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI